2,5-Dimethoxy-4-isopropylamphetamine

2,5-Dimethoxy-4-isopropylamphetamine

2,5-Dimethoxy-4-isopropylamphetamine
Systematic (IUPAC) name
1-(2,5-Dimethoxy-4-isopropyl-phenyl)propan-2-amine
Identifiers
CAS Registry Number
53581-56-9 (hydrochloride salt)
PubChem CID:
ChemSpider
Chemical data
Formula C14H23NO2
Molecular mass 237.34 g·mol−1

2,5-Dimethoxy-4-isopropylamphetamine (also known as DOiP and DOiPR) is a synthesized by Alexander Shulgin, and was described in his book PiHKAL (Phenethylamines i Have Known And Loved). Shulgin described DOiPR as being at least an order of magnitude weaker than DOPr, with doses of 20–30 mg required to produce valid changes in mental state.[4] Very little data exists about the pharmacological properties, metabolism, and toxicity of DOiPR.

See also

References

  1. ^ Richard A. Glennon, Mark R. Seggel (November 1989). "Interaction of phenylisopropylamines with central 5-HT2 receptors. Analysis by quantitative structure-activity relationships.". ACS Symposium Series 413: 264–280.  
  2. ^ Mark R. Seggel, M. Y. Yousif, Robert A. Lyon, Milt Titeler, Bryan L. Roth, Eva A. Suba, Richard A. Glennon (March 1990). "A structure-affinity study of the binding of 4-substituted analogs of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors". Journal of Medicinal Chemistry 33 (3): 1032–1036.  
  3. ^ F. A. B. Aldous, B. C. Barrass, K. Brewster, D. A. Buxton, D. M. Green, R. M. Pinder, P. Rich, M. Skeels, K. J. Tutt (October 1974). "Structure-activity relations in psychotomimetic phenylalkylamines". Journal of Medicinal Chemistry 17 (10): 1100–1111.  
  4. ^ Shulgin, Alexander; Shulgin, Ann (September 1991). "PiHKAL: A Chemical Love Story #71 DOPR". Transform Press. p. 978. Retrieved 27 June 2015.